Ian Pavord

Also affiliated with John Radcliffe Hospital, National Institute for Health and Care Research, University of Oxford, Oxford BioMedica (United Kingdom)

MedicineSocial Sciences

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 1%percentile

7.7Author DataRank

Indexed papers

1in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

Novel insights into the genetics of smoking behaviour, lung function, and chronic obstructive pulmonary disease (UK BiLEVE): a genetic association study in UK Biobank

The Lancet Respiratory Medicine(2015)10.1016/s2213-2600(15)00283-0

Top 2%

7.7DataRank

Top 2%438 citations

Nick Shrine, Suzanne Miller, Victoria E. Jackson, Ioanna Ntalla, María Soler Artigas +39 more

Papers

Driven by 18 papers — median percentile 98. Top paper: “Novel insights into the genetics of smoking behaviour, lung function, and chronic obstructive pulmonary disease (UK BiLEVE): a genetic association study in UK Biobank”.

Novel insights into the genetics of smoking behaviour, lung function, and chronic obstructive pulmonary disease (UK BiLEVE): a genetic association study in UK Biobank

The Lancet Respiratory Medicine(2015)10.1016/s2213-2600(15)00283-0

Top 2%

7.7DataRank

Top 2%438 citations

Nick Shrine, Suzanne Miller, Victoria E. Jackson, Ioanna Ntalla, María Soler Artigas +39 more

Baseline FeNO as a prognostic biomarker for subsequent severe asthma exacerbations in patients with uncontrolled, moderate-to-severe asthma receiving placebo in the LIBERTY ASTHMA QUEST study: a post-hoc analysis

The Lancet Respiratory Medicine(2021)10.1016/s2213-2600(21)00124-7

N/A

4.3DataRank · unranked

143 citations

Sally E. Wenzel, Thomas B. Casale, J. Mark FitzGerald, Megan S. Rice, Nadia Daizadeh +8 more

Baseline FeNO Independently Predicts the Dupilumab Response in Patients With Moderate-to-Severe Asthma

The Journal of Allergy and Clinical Immunology In Practice(2022)10.1016/j.jaip.2022.11.043

N/A

3.0DataRank · unranked

91 citations

Yamo Deniz, Jonathan Corren, Thomas B. Casale, J Mark FitzGerald, Kenji Izuhara +10 more

Clinical response and on-treatment clinical remission with tezepelumab in a broad population of patients with severe, uncontrolled asthma: results over 2 years from the NAVIGATOR and DESTINATION studies

European Respiratory Journal(2024)10.1183/13993003.00316-2024

N/A

1.4DataRank · unranked

43 citations

Guy Brusselle, J. Christian Virchow, Arnaud Bourdin, Κonstantinos Κostikas, Jean‐Pierre Llanos +10 more

Dupilumab Is Effective in Patients With Moderate-to-Severe Uncontrolled GINA-Defined Type 2 Asthma Irrespective of an Allergic Asthma Phenotype

The Journal of Allergy and Clinical Immunology In Practice(2022)10.1016/j.jaip.2022.06.036

N/A

1.2DataRank · unranked

24 citations

J. Mark FitzGerald, Eric D. Bateman, Mario Castro, Ian Pavord, Jorge Máspero +8 more

Patient characteristics, biomarkers and exacerbation risk in severe, uncontrolled asthma

European Respiratory Journal(2021)10.1183/13993003.00413-2021

N/A

0DataRank · unranked

72 citations

Guy Brusselle, J. Mark FitzGerald, Ian Pavord, M. Keith, Malin Fagerås +5 more

Effective Management of Severe Asthma with Biologic Medications in Adult Patients: A Literature Review and International Expert Opinion

The Journal of Allergy and Clinical Immunology In Practice(2021)10.1016/j.jaip.2021.10.059

N/A

0DataRank · unranked

62 citations

Elisabeth H. Bel, Arnaud Bourdin, Ignacio Dávila, John Aubrey Douglass, J. Mark FitzGerald +7 more

Moving towards a Treatable Traits model of care for the management of obstructive airways diseases

Respiratory Medicine(2021)10.1016/j.rmed.2021.106572

N/A

0DataRank · unranked

56 citations

Neil Barnes, Álvaro A. Cruz, Peter G. Gibson, Liam G. Heaney, Hiromasa Inoue +10 more

Eosinophil Knockout Humans: Uncovering the Role of Eosinophils Through Eosinophil-Directed Biological Therapies

Annual Review of Immunology(2021)10.1146/annurev-immunol-093019-125918

N/A

0DataRank · unranked

144 citations

David J. Jackson, Enrico Heffler, Sameer K. Mathur, Albert J. Bredenoord, Ian Pavord +4 more

Using fractional exhaled nitric oxide to guide step-down treatment decisions in asthma: practical considerations

European Respiratory Journal(2020)10.1183/13993003.02809-2020

N/A

0DataRank · unranked

2 citations

Jan Y. Verbakel, Jason Oke, Alex Fleming‐Nouri, Norihiro Harada, Ryo Atsuta +10 more

Efficacy of dupilumab in patients with moderate-to-severe asthma and persistent airflow obstruction

Annals of Allergy Asthma & Immunology(2022)10.1016/j.anai.2022.10.018

N/A

0DataRank · unranked

16 citations

Mario Castro, Eric D. Bateman, Ian Pavord, Alberto Papi, J. Mark FitzGerald +15 more

Improving Care in Eosinophil-Associated Diseases: A Charter

Advances in Therapy(2022)10.1007/s12325-022-02110-8

N/A

0DataRank · unranked

13 citations

Praveen Akuthota, Rebeca Andradas, Albert J. Bredenoord, Amanda Cordell, Sarah A. O. Gray +10 more

Global Initiative for Chronic Obstructive Lung Disease 2023 Report: GOLD Executive Summary

European Respiratory Journal(2023)10.1183/13993003.00239-2023

N/A

0DataRank · unranked

1249 citations

Bartolomé R. Celli, Gerard J. Criner, David Halpin, Antonio Anzueto, Peter J. Barnes +16 more

Type 2 inflammation and biological therapies in asthma: Targeted medicine taking flight

The Journal of Experimental Medicine(2023)10.1084/jem.20221212

N/A

0DataRank · unranked

81 citations

Aleksandra Howell, Ian Pavord, Imran Howell

Clinical Development of Mepolizumab for the Treatment of Severe Eosinophilic Asthma: On the Path to Personalized Medicine

The Journal of Allergy and Clinical Immunology In Practice(2020)10.1016/j.jaip.2020.08.039

N/A

0DataRank · unranked

37 citations

Andrew Menzies‐Gow, Roland Buhl, Pascal Chanez, Mark T. Dransfield, Njira Lugogo +4 more

CLINICAL EFFICACY OF DUPILUMAB TREATMENT DURING WITHDRAWAL OF INHALED CORTICOSTEROIDS/LONG-ACTING BETA AGONISTS

CHEST Journal(2024)10.1016/j.chest.2024.06.2860

N/A

0DataRank · unranked

0 citations

David S. Jackson, KLAUS F RABE, Ian Pavord, J. Christian Virchow, Rohit Katial +9 more

Inflammatory and clinical risk factors for asthma attacks (ORACLE2): a patient-level meta-analysis of control groups of 22 randomised trials

The Lancet Respiratory Medicine(2025)10.1016/s2213-2600(25)00037-2

N/A

0DataRank · unranked

76 citations

Samuel Mailhot-Larouche, Carlos A. Celis-Preciado, Samuel Lemaire‐Paquette, Sanjay Ramakrishnan, Michael E. Wechsler +22 more

Transient early blood eosinophil increases do not affect dupilumab’s long-term efficacy in patients with moderate-to-severe asthma

Journal of Allergy and Clinical Immunology(2025)10.1016/j.jaci.2025.07.037

N/A

0DataRank · unranked

1 citations

Njira Lugogo, Mario Castro, Alberto Papi, Arnaud Bourdin, Michael E. Wechsler +8 more

Ian Pavord

Indexed papers

Top data-sharing exemplar

Papers